IndraLab

Statements


| 1

reach
"EBV LMP2A reduces MICA and ULBP4 in lymphoblastoid cell lines and inhibits recognition by CD8+ T cells [XREF_BIBR], and this allows it to block its recognition and destruction by NK cells."